Stark Victoria A, Facey Caroline O B, Opdenaker Lynn, Fields Jeremy Z, Boman Bruce M
Department of Biological Sciences, University of Delaware, Newark, DE 19716, USA.
Center for Translational Cancer Research, Helen F. Graham Cancer Center & Research Institute, Newark, DE 19713, USA.
bioRxiv. 2023 Feb 6:2023.02.06.527341. doi: 10.1101/2023.02.06.527341.
One reason for lack of efficacy in cancer therapeutics is tumor heterogeneity. We hypothesize that tumor heterogeneity arises due to emergence of multiple cancer stem cell (CSC) subpopulations because miRNAs regulate expression of stem cell genes in CSCs. Our goal was to determine if: ) multiple CSC subpopulations exist in a human CRC cell population, and ) miRNAs are differentially expressed in the different CSC subpopulations. We discovered that at least four different CSC populations (ALDH1, CD166, LGR5, LRIG1) exist in the HT29 cell line. CSC subpopulations were quantified using co-staining for multiple stem cell markers, isolated using FACS, and analyzed by NanoString miRNA profiling. The miRNA expression pattern in each CSC subpopulation was analyzed relative to miRNA expression patterns in other CSC subpopulations. Messenger RNAs predicted to be targeted by the upregulated miRNAs in each CSC subpopulation were: 1) identified using bioinformatics analyses, and 2) classified according to their predicted functions using David functional annotation analyses. We found multiple CSC subpopulations with a unique miRNA signature in each CSC subpopulation. Notably, the miRNAs expressed within one CSC subpopulation are predicted to target and downregulate the CSC genes and pathways that establish the other CSC subpopulations. Moreover, mRNAs predicted to be targeted by miRNAs in the different CSC subpopulations have different cellular functional classifications. That different CSC subpopulations express miRNAs that are predicted to target CSC genes expressed in other CSC subpopulations provides a mechanism that might explain the co-existence of multiple CSC subpopulations, tumor heterogeneity, and cancer therapy resistance.
癌症治疗中缺乏疗效的一个原因是肿瘤异质性。我们假设肿瘤异质性是由于多个癌症干细胞(CSC)亚群的出现而产生的,因为微小RNA(miRNA)调节CSC中干细胞基因的表达。我们的目标是确定:1)人类结直肠癌细胞群中是否存在多个CSC亚群,以及2)miRNA在不同的CSC亚群中是否差异表达。我们发现HT29细胞系中至少存在四种不同的CSC群体(醛脱氢酶1、CD166、富含亮氨酸重复序列的G蛋白偶联受体5、富含亮氨酸重复免疫球蛋白结构域1)。使用多种干细胞标志物的共染色对CSC亚群进行定量,通过荧光激活细胞分选(FACS)进行分离,并通过NanoString miRNA分析进行分析。相对于其他CSC亚群中的miRNA表达模式,分析了每个CSC亚群中的miRNA表达模式。预计在每个CSC亚群中被上调的miRNA靶向的信使核糖核酸(mRNA):1)使用生物信息学分析进行鉴定,2)使用大卫功能注释分析根据其预测功能进行分类。我们在每个CSC亚群中发现了具有独特miRNA特征的多个CSC亚群。值得注意的是,预计在一个CSC亚群中表达的miRNA会靶向并下调建立其他CSC亚群的CSC基因和信号通路。此外,预计在不同CSC亚群中被miRNA靶向的mRNA具有不同的细胞功能分类。不同的CSC亚群表达预计靶向其他CSC亚群中表达的CSC基因的miRNA,这提供了一种机制,可能解释多个CSC亚群的共存、肿瘤异质性和癌症治疗抗性。